Navigation Links
CriticalPoint(TM) Introduces Crosswalk Tool for Sterile Compounding Regulatory Requirements
Date:7/30/2008

CriticalPoint, LLC, in partnership with Baxa Corporation, announces the availability of a free online reference tool for understanding state laws

and regulations related to sterile compounding and USP compliance.

ENGLEWOOD, Colo., July 30 /PRNewswire/ -- Baxa Corporation announces the availability of a comprehensive new reference tool for understanding the compliance requirements for sterile compounding and USP < 797 > compliance. The interactive reference map was developed by ClinicalIQ, LLC, CriticalPoint, LLC and the National Association of Boards of Pharmacy(R). The tool offers state-specific guidelines on professional licensing and training requirements, State Board of Pharmacy harmonization with USP < 797 > guidelines and sterile compounding laws.

According to Peter Cantor, CriticalPoint development lead, "This project was developed as a response to the need among pharmacy managers and other healthcare providers to understand the legal and professional requirements for sterile compounding and licensure. As a provider of continuing education and USP < 797 > compliance training for pharmacies, we wanted to take this opportunity to give something back to the compounding community. The research provides an important tool for our customers in understanding the laws and regulations that govern their work." The complimentary reference tool is available online and is maintained by Cantor and other CriticalPoint staff members.

Baxa Corporation markets the CriticalPoint compliance training modules as part of its Productivity and Compliance Tools (PACT) product line, which includes the Skills Training, Academics and Resources (STAR) Center classroom-based training for USP < 797 > compliance and aseptic compounding. The CriticalPoint program offers an interactive, Web-based training solution for sterile compounding education and regulatory compliance. The online crosswalk tool complements the CriticalPoint training by providing up-to-date information on the training requirements in each state for professional licensure, USP < 797 > and state laws and regulations.

Notes pharmacist Phil Wettestad, Baxa Pharmacy Operations Specialist, "This crosswalk tool is a valuable resource for pharmacy managers and IV supervisors for determining their training needs and planning for regulatory compliance." Once a facility's training needs are established, the CriticalPoint - Baxa partnership provides both off-the-shelf and experiential training programs to meet them." For more information on sterile compounding compliance training programs, visit http://www.baxa.com/criticalpoint.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.

About CriticalPoint, LLC

CriticalPoint, LLC, offers interactive Web-based training for compounding sterile preparations and services related to creating and enabling learning through technology in clinical settings. CriticalPoint e-Learning represents a best practices approach for interactive training for sterile compounding and is designed to assist healthcare providers in meeting quality assurance program goals and regulatory compliance. For more information visit http://www.criticalpoint.info.

About NABP(R)

The National Association of Boards of Pharmacy (NABP) is the independent, international, and impartial association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health. http://www.nabp.net/

Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com

Peter Cantor

CriticalPoint, LLC : 240-238-4352

Email: pcantor@criticalpoint.info


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
2. Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
3. Nikon Instruments Introduces New Microscopes and Illumination Stand for Education and OEM Markets
4. Liko Introduces Two Additions to Its Stat Family of Low Friction Sheets
5. Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R)
6. Berkley Life Sciences Introduces LS Prime: A Revolutionary New Primary Liability Policy for the Life Science Industry
7. Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine
8. LI-COR(R) Biosciences Introduces New Tools for High Throughput Western Blotting
9. Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
10. Braemar Introduces the ER920W Wireless Cardiac Arrhythmia Monitor
11. LI-COR Biosciences Introduces Near-Infrared Small Animal Imager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 29, 2017 , ... ComplianceOnline, the leading governance, risk and compliance advisory network ... Device Summit 2017 venue and speaker lineup. The Summit will take place on June ... The Omni Parker House Hotel, which is located at 60 School Street, Boston, MA ...
(Date:3/29/2017)... 2017  Halozyme Therapeutics, Inc. (NASDAQ: HALO), a ... today announced that an Oncologic Drug Advisory Committee ... 11 to 0 that the benefit/risk of rituximab/hyaluronidase ... for patients in the proposed indications of follicular ... leukemia. The FDA action date is June 26, ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... edge instrumentation for cell-based assays, disperses a quarterly travel award to noteworthy scientists ... Today the company announced that its new round of awards are being given ...
(Date:3/29/2017)... ... March 29, 2017 , ... Bactana Animal Health, a company developing natural products ... through enhancement of the gut microbiota, today announced the closing of its first round ... York-based Sustainable Income Capital Management, LLC and a number of private investors. The company ...
Breaking Biology Technology:
(Date:3/2/2017)... -- Who risk to be deprived of its imprint ... https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG CONFRONT ... sensors using capacitive technology represent a fast growing market, ... an increase of 360% of the number of fingerprint ... sensor market between 2014 and 2017 (source : N+1 ...
(Date:2/28/2017)... Germany , February 28, 2017 News ... ... Amsterdam from 14 to 16 March, Materna ... destination, and show how seamless travel is a real benefit for ... has added biometrics to their passenger touch point solutions to take ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader of ... elite iris biometric solution on the latest Qualcomm® ... at Mobile World Congress 2017 (February 27 ... in Hall 3, Stand 3E10. ... Haven™ security platform—a combination of hardware, software ...
Breaking Biology News(10 mins):